Back to TCRX
JPMORGAN CHASE & CO TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
15
Latest value
$48
Q3 2026
Peak value
$399K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $6K |
| Q3 2025 | $399K |
| Q3 2025 | $27K |
| Q4 2025 | $4K |
| Q4 2025 | $15K |
| Q4 2025 | $15K |
| Q1 2026 | $1K |
| Q1 2026 | $244 |
| Q1 2026 | $14K |
| Q2 2026 | $1K |
| Q2 2026 | $275 |
| Q2 2026 | $15K |
| Q3 2026 | $374 |
| Q3 2026 | $123 |
| Q3 2026 | $48 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $48 | 150 | — | — |
| Q3 2026 | $123 | 388 | — | — |
| Q3 2026 | $374 | 1.2K | — | — |
| Q2 2026 | $15K | 15.0K | — | — |
| Q2 2026 | $275 | 281 | — | — |
| Q2 2026 | $1K | 1.2K | — | — |
| Q1 2026 | $14K | 15.0K | — | — |
| Q1 2026 | $244 | 259 | — | — |
| Q1 2026 | $1K | 1.2K | — | — |
| Q4 2025 | $15K | 15.0K | — | — |
| Q4 2025 | $15K | 14.5K | — | — |
| Q4 2025 | $4K | 3.8K | — | — |
| Q3 2025 | $27K | 15.0K | — | — |
| Q3 2025 | $399K | 219.3K | — | — |
| Q3 2025 | $6K | 3.4K | — | — |
Other funds holding TCRX
$630M
$630M
$617.5M
$198.1M
$10.9M